Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-1/PD-L1 and DNA Damage Response in Cancer
Mateusz Kciuk, Damian Kołat, Żaneta Kałuzińska‐Kołat, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 530-530
Open Access | Times Cited: 22

Showing 22 citing articles:

Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activity
Mateusz Kciuk, Adrianna Gielecińska, Somdutt Mujwar, et al.
Cells (2023) Vol. 12, Iss. 4, pp. 659-659
Open Access | Times Cited: 267
PD-1 and PD-L1: architects of immune symphony and immunotherapy breakthroughs in cancer treatment
Adil Parvez, Furqan Choudhary, Priyal Mudgal, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 57
Recent Advances in Molecular Mechanisms of Cancer Immunotherapy
Mateusz Kciuk, Esam Bashir Yahya, Montaha Mohamed Ibrahim Mohamed, et al.
Cancers (2023) Vol. 15, Iss. 10, pp. 2721-2721
Open Access | Times Cited: 41
Epigallocatechin-3-Gallate Therapeutic Potential in Cancer: Mechanism of Action and Clinical Implications
Mateusz Kciuk, Manzar Alam, Nemat Ali, et al.
Molecules (2023) Vol. 28, Iss. 13, pp. 5246-5246
Open Access | Times Cited: 36
Mitochondrial Signaling Pathways Associated with DNA Damage Responses
Tsutomu Shimura
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 7, pp. 6128-6128
Open Access | Times Cited: 23
Potential role of p53 deregulation in modulating immune responses in human malignancies: A paradigm to develop immunotherapy
Shivi Chauhan, Shivani Jaiswal, Vibhuti Jakhmola, et al.
Cancer Letters (2024) Vol. 588, pp. 216766-216766
Open Access | Times Cited: 11
The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 9
Ferroptosis and cuproptosis: Metal-dependent cell death pathways activated in response to classical chemotherapy – Significance for cancer treatment?
Mateusz Kciuk, Adrianna Gielecińska, Żaneta Kałuzińska‐Kołat, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 4, pp. 189124-189124
Open Access | Times Cited: 8
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation
Zachary S. Morris, Sandra Demaria, Arta M. Monjazeb, et al.
The Lancet Oncology (2025) Vol. 26, Iss. 3, pp. e152-e170
Closed Access
SMYD2 inhibition–mediated hypomethylation of Ku70 contributes to impaired nonhomologous end joining repair and antitumor immunity
Ming Tang, Guofang Chen, Bo Tu, et al.
Science Advances (2023) Vol. 9, Iss. 24
Open Access | Times Cited: 12
Target protein degradation by protacs: A budding cancer treatment strategy
Diksha Choudhary, Amritpal Kaur, Pargat Singh, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108525-108525
Closed Access | Times Cited: 12
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 3
Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway
Jianyu Shen, Emilio Guillén Mancina, Shenyu Chen, et al.
Oncogenesis (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 3
N6-methyladenosine reader protein IGF2BP1 suppresses CD8 + T cells-mediated tumor cytotoxicity and apoptosis in colon cancer
Yao Peng, Zhili Zhang, Gong‐Li Yang, et al.
APOPTOSIS (2023) Vol. 29, Iss. 3-4, pp. 331-343
Closed Access | Times Cited: 9
Bioactive Compounds of Dietary Origin and Their Influence on Colorectal Cancer as Chemoprevention
Paulina Delgado‐González, Elsa N. Garza-Treviño, David A. De la Garza Kalife, et al.
Life (2023) Vol. 13, Iss. 10, pp. 1977-1977
Open Access | Times Cited: 5
Intratumoral lactic acid neutralization strategy for boosting chemoimmunotherapy using liposomal sodium bicarbonate
Taoxing Peng, Xinyue Shao, Wenqin Song, et al.
Science Bulletin (2024)
Closed Access | Times Cited: 1
It’s high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer
Shiya Yao, Yuejun Han, Mengxiang Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 3
PD-1/PD-L1 Inhibitors for the Treatment of Lung Cancer
Yuvraj Patil, Bariz Dakhni, Shweta Kolhatkar
(2024), pp. 65-86
Closed Access
Exploring RPA1-ETAA1 axis via high-throughput data analysis: implications for PD-L1 nuclear translocation and tumor-immune dynamics in liver cancer
Gaofeng Qin, Zengkuan Chen, Weihong Tian, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access
PD-L1 expression is mediated by microRNA processing, Wnt/β-catenin signaling, and chemotherapy in Wilms tumor
Kavita Desai, Patricia D.B. Tiburcio, Austin Warne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Morphometric analysis of nuclear shape irregularity as a novel predictor of programmed death-ligand 1 expression in lung squamous cell carcinoma
Ryoko Saito, Keiichi Tamai, Jun Yasuda, et al.
Virchows Archiv (2023) Vol. 484, Iss. 4, pp. 609-620
Closed Access
Mitotic MTH1 inhibitor TH1579 induces PD-L1 expression and inflammatory response through the cGAS-STING pathway
Thomas Helleday, Jianyu Shen, Emilio Guillén Mancina, et al.
Research Square (Research Square) (2023)
Open Access
Page 1

Scroll to top